Retractable Technologies, Inc. is engaged in the business of designing, developing, manufacturing and marketing of patented safety medical products for the healthcare industry. VanishPoint products retract the needle directly from the patient, reducing exposure to the contaminated needle. The Company�s VanishPoint safety needle products consist of one milliliter tuberculin, insulin, and allergy antigen VanishPoint syringes; 0.5 milliliter, two milliliter, three milliliter, five milliliter, and 10 milliliter VanishPoint syringes; the VanishPoint blood collection tube holder; autodisable syringe, and the VanishPoint IV safety catheter. The Company also has a Patient Safe syringe which is designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The Company is selling autodisable syringes in the international market in addition to its other products.